Scott Wagner - 03 Jun 2025 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Reporting relationship: Director
Issuer ticker: GDRX
Reported as of: 03 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Jun 2025, 18:48:39 UTC
Prior SEC filing: 23 May 2025
Next SEC filing: 03 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Gracye Cheng, Attorney-in-Fact for Scott Wagner

Key filing fact

Scott Wagner filed Form 4 for GoodRx Holdings, Inc. (GDRX) on 04 Jun 2025.

Key facts

This page summarizes Scott Wagner's Form 4 filing for GoodRx Holdings, Inc. (GDRX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Jun 2025, 18:48.

Change

Previous filing in this sequence was filed on 23 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001342655 Primary reporting owner

Wagner Scott

Relationship: Director
Address: C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA
Signature: /s/ Gracye Cheng, Attorney-in-Fact for Scott Wagner
Signature date: 04 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GDRX transaction

Class A Common Stock

Award

Transaction value: $0
Shares: +57,050
Change %: +46%
Price: $0.000000
Shares after: 182,204
Date: 03 Jun 2025
Ownership: Direct
Footnotes: F1

GDRX holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 182,900
Date: 03 Jun 2025
Ownership: By Wagner Family Trust
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units vest in full on the earlier of (i) the one-year anniversary of June 3, 2025 and (ii) the date of the 2026 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).

Footnote F2

Shares held directly by the Wagner Family Trust (the "Trust"). The Reporting Person and his spouse serve as trustees of the Trust, and the Reporting Person, his spouse and other members of his immediate family are the sole beneficiaries of the Trust.